Pulling investors back to biotech: A job for tax reforms
This article was originally published in Scrip
Executive Summary
Biotechs are hoping legislation introduced in the Senate this week by Senators Robert Menendez (Democrat-New Jersey) and Pat Toomey (Republican-Pennsylvania) will reverse an action Congress took in 1986 that essentially removed the very mechanism that drove the investment that created some of the most innovative companies in the US.